1. Novel Variant in ANO5 Muscular Dystrophy: Identification by Whole Genome Sequencing and Quad Analysis.
- Author
-
Ćuk M, Unal B, Lovrenčić L, Walker M, Hayes CP, Abraamyan F, Prutki M, Krakar G, Srkoč-Majčica L, and Ghazani AA
- Subjects
- Humans, Female, Adolescent, Muscular Dystrophies genetics, Muscular Dystrophies diagnosis, Muscular Dystrophies pathology, Mutation, Phenotype, Pedigree, Heterozygote, Anoctamins genetics, Whole Genome Sequencing methods
- Abstract
Background: The phenotypic spectrum of ANO5 muscle disease ranges widely from elevated creatine kinase (CK) levels in the serum of asymptomatic individuals to progressive muscular dystrophy. Due to overlapping clinical features among muscular dystrophies, the diagnosis of ANO5 muscle disease is established by molecular genetic tests. Early diagnosis is crucial for the clinical management of symptoms and to mitigate cardiac and musculoskeletal complications., Methods: Quad-joint analysis was performed on whole genome sequencing (WGS) data obtained from an 18-year-old female with mild myalgia and elevated CK and her unaffected parents and sister. The phenotype-driven analysis was performed to prioritize genomic alterations related to the phenotype. The zygosity-based analysis investigated compound heterozygous and de novo status for all variants., Results: The quad-joint WGS analysis revealed a novel pathogenic heterozygous variant, ANO5 :c.1770_1773del (p.Phe593Metfs*15), that was paternally inherited. A second and known pathogenic heterozygous variant, ANO5 :c.148C>T (p.Arg50*), was also present that was maternally inherited. The genome finding led to the diagnosis of autosomal recessive ANO5 muscle disease and an early personalized clinical management for the patient regarding her cardiac and musculoskeletal health., Conclusions: This is the first report of the ANO5 :c.1770_1773del variant in the literature. This report highlights the spectrum of ANO5 muscle disease and describes the role of quad-joint WGS in the early diagnosis and preventive clinical management of ANO5 muscle disease.
- Published
- 2024
- Full Text
- View/download PDF